Home / United Kingdom / Sartorius Stedim Biotech
Sartorius Stedim Biotech
Short position disclosed on August 6, 2026.
1.72% of the capital sold short
? funds not named
29 disclosures on record
Since 13 July 2026 this regulator publishes an aggregated total per company and no longer names the funds. Positions disclosed before that date remain nominative.
Evolution of the disclosed total
0%0.5%1%1.5%2%
Oct 2025Jan 2026Apr 2026Jul 2026
November 3, 2023 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Aggregated total | 1.72% | new | August 6, 2026 |
On the other side: the funds that hold Sartorius Stedim Biotech Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 6, 2026 | Aggregated total | 1.72% | still open |
| July 27, 2026 | Aggregated total | 1.52% | August 6, 2026 |
| July 24, 2026 | Aggregated total | 1.72% | July 27, 2026 |
| July 13, 2026 | Aggregated total | 1.52% | July 24, 2026 |
| July 8, 2026 | Aggregated total | 0.81% | July 13, 2026 |
| May 19, 2026 | AQR Capital Management, LLC | 0.49% | May 21, 2026 |
| May 13, 2026 | AQR Capital Management, LLC | 0.50% | May 21, 2026 |
| July 18, 2025 | AQR Capital Management, LLC | 0.49% | July 22, 2025 |
| May 7, 2025 | AQR Capital Management, LLC | 0.50% | July 22, 2025 |
| January 24, 2025 | AQR Capital Management, LLC | 0.49% | January 28, 2025 |
| January 17, 2025 | AQR Capital Management, LLC | 0.50% | January 28, 2025 |
| December 6, 2024 | Qube Research & Technologies Limited | 0.01% | December 10, 2024 |
| December 5, 2024 | Qube Research & Technologies Limited | 0.50% | December 10, 2024 |
| December 4, 2024 | Qube Research & Technologies Limited | 0.49% | December 6, 2024 |
| December 3, 2024 | Qube Research & Technologies Limited | 0.50% | December 6, 2024 |
| November 29, 2024 | Qube Research & Technologies Limited | 0.49% | December 3, 2024 |
| November 28, 2024 | Qube Research & Technologies Limited | 0.50% | December 3, 2024 |
| November 27, 2024 | Qube Research & Technologies Limited | 0.49% | November 29, 2024 |
| November 20, 2024 | Qube Research & Technologies Limited | 0.50% | November 29, 2024 |
| October 29, 2024 | Qube Research & Technologies Limited | 0.49% | October 31, 2024 |
| September 19, 2024 | Qube Research & Technologies Limited | 0.50% | October 31, 2024 |
| September 16, 2024 | Qube Research & Technologies Limited | 0.49% | September 18, 2024 |
| August 23, 2024 | Qube Research & Technologies Limited | 0.50% | September 18, 2024 |
| August 22, 2024 | Qube Research & Technologies Limited | 0.49% | August 26, 2024 |
| August 16, 2024 | Qube Research & Technologies Limited | 0.50% | August 26, 2024 |
| July 12, 2024 | AQR Capital Management, LLC | 0.49% | July 16, 2024 |
| April 24, 2024 | AQR Capital Management, LLC | 0.50% | July 16, 2024 |
| November 16, 2023 | AQR Capital Management, LLC | 0.49% | November 20, 2023 |
| November 3, 2023 | AQR Capital Management, LLC | 0.50% | November 20, 2023 |
Other companies sold short in the United Kingdom
- Ibstock PLC 20.73% of the capital sold short
- Vistry Group PLC 19.98% of the capital sold short
- Capita PLC 13.67% of the capital sold short
- Ocado Group PLC 12.09% of the capital sold short
- WH Smith PLC 11.69% of the capital sold short
- Wizz Air Holdings PLC 11.60% of the capital sold short
- Chemring Group PLC 11.42% of the capital sold short
- Genuit Group PLC 11.14% of the capital sold short
- Crest Nicholson Holdings PLC 11.01% of the capital sold short
- Ceres Power Holdings PLC 10.66% of the capital sold short
- Greggs PLC 10.57% of the capital sold short
- R&S Group Holding AG 10.20% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Sartorius Stedim Biotech, source FCA, data as at August 6, 2026, https://www.quivad.com/action/sartorius-stedim-biotech